BUFORD, Ga.--(BUSINESS WIRE)--Theragenics Corporation® (NYSE: TGX) is pleased to announce that Chairman and CEO M. Christine Jacobs along with the Board of Directors and management representatives will Ring the Closing Bell at the New York Stock Exchange (NYSE) Monday afternoon, August 18 to commemorate the Company’s ten-year listing anniversary. Theragenics is a medical device company headquartered near Atlanta, Georgia, serving the surgical products and prostate cancer treatment markets.
